NC Registry

There is a clinical trial utilizing a dual BET and CBP/p300 inhibitor in adult patients with targeted advanced solid tumors (including NUT Carcinoma). Additional information about this trial can be found at the following link:
https://clinicaltrials.gov/study/NCT05488548?term=NCT05488548&rank=1

A new clinical trial sponsored by Boehringer Ingelheim is currently enrolling NMC patients!!! Enrollment will open in the US at the MD Anderson Cancer Center in Houston, TX followed by DFCI in Boston, MA during the first quarter of 2019.

Please see the link below for more information:

BI 894999 First in Human Dose Finding Study in Advanced Malignancies - Full Text View - ClinicalTrials.gov BI 894999 First in Human Dose Finding Study in Advanced Malignancies - Full Text View.